Physicochemical properties of benzoic acid N,N-dialkylhydrazides
摘要:
Benzoic acid N,N-dialkylhydrazides of the general formula C6H5C(O)NHNR2, R = C4H9, C6H13, C8H17, C10H21, were obtained,. Their solubility, acid-base properties, stability against hydrolysis, distribution between organic and water phases were studied.
Expandable and curable polyester composition and method for making same
申请人:UNIROYAL, INC.
公开号:EP0083173A1
公开(公告)日:1983-07-06
An expandable and curable polyester composition comprising a mixture of a liquid, ethylenically unsaturated polyester resin composition; a peroxide; an organometallic promotor; and a dialkyl or trialkyl hydrazine is disclosed. In addition, a method for forming said expanded and cured polyester resin composition, and the product formed in accordance with said method, an expanded and cured polyester resin composition, is taught.
Lipophilic derivatives of double-stranded ribonucleic acid
申请人:Alnylam Europe AG
公开号:EP1852506A2
公开(公告)日:2007-11-07
The present invention relates to a double-stranded ribonucleic acid (dsRNA) having improved efficiency of inhibition of gene expression, methods of making the dsRNA, and pharmaceutical compositions comprising the dsRNA. The dsRNA comprises an RNA strand (complementary RNA strand) having a region which is complementary to an RNA transcript of at least a part of a target gene, and at least one covalently linked lipophilic group. The dsRNA are useful for inhibiting the expression of a target gene, as well as for treating diseases caused by expression of the target gene. The invention also relates to methods for inhibiting the expression of a target gene, as well as methods for treating diseases caused by the expression of the gene.
LIPOPHILIC DERIVATIVES OF DOUBLE-STRANDED RIBONUCLEIC ACID
申请人:Alnylam Europe AG
公开号:EP1587926A2
公开(公告)日:2005-10-26
US4397965A
申请人:——
公开号:US4397965A
公开(公告)日:1983-08-09
[EN] LIPOPHILIC DERIVATIVES OF DOUBLE-STRANDED RIBONUCLEIC ACID<br/>[FR] DERIVES LIPOPHILES D'ACIDE RIBONUCLEIQUE A DOUBLE BRIN
申请人:RIBOPHARMA AG
公开号:WO2004065601A2
公开(公告)日:2004-08-05
The present invention relates to a double-stranded ribonucleic acid (dsRNA) having improved efficiency of inhibition of gene expression, methods of making the dsRNA, and pharmaceutical compositions comprising the dsRNA. The dsRNA comprises an RNA strand (complementary RNA strand) having a region which is complementary to an RNA transcript of at least a part of a target gene, and at least one covalently linked lipophilic group. The dsRNA are useful for inhibiting the expression of a target gene, as well as for treating diseases caused by expression of the target gene. The invention also relates to methods for inhibiting the expression of a target gene, as well as methods for treating diseases caused by the expression of the gene.